Medical Marijuana, Inc. (OTC: MJNA) this morning announced that the company and its subsidiaries, Kannaway® and HempMeds®, have achieved the largest-ever sales revenue quarter in their history during Q1 2018. The company also reached major milestones in its business operations, including immense expansion and continued growth demonstrated by its HempMeds subsidiary and continued growth in Europe by its Kannaway subsidiary. Per the update, the company’s first quarter revenues surpassed $10.5 million, an increase of more than 190% over the same period of the previous year. Total gross profits for Q1 2018 also recognized an increase of more than 30% as compared to Q1 2017. “In Q1 2018, we had the best revenue quarter in the history of our company,” Medical Marijuana, Inc. CEO Dr. Stuart Titus stated in the news release. “We’re excited that, with the help of our investors, spokespeople and customers, we’ve experienced tremendous growth and the company is positioned well for continued explosive expansion.”
To view the full press release, visit http://cnw.fm/75feX
About Medical Marijuana, Inc.
Medical Marijuana Inc. is a cannabis and hemp industry innovator, leveraging its team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. The company strives to create awareness within the industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, visit the company’s website at www.medicalmarijuanainc.com.
More from CannabisNewsBreaks
About HempWire
HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and…
InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with…
CannabisNewsWire (CNW), a trusted communications platform within the cannabis sector and a part of InvestorBrandNetwork…
Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…
WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…
Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…